Management of a patient with acute myeloid leukaemia with a diagnosis of type 2 von Willebrand disease and a novel variant within the von Willebrand factor (VWF) gene

Br J Haematol. 2022 Oct;199(2):e5-e7. doi: 10.1111/bjh.18390. Epub 2022 Jul 29.

Authors

James Dillon¹, Vitaliy Mykytiv¹, Catriona Keenan², Brendan Mullaney², Nina Orfali³, Kevin Ryan², Cleona Duggan¹, Maeve P Crowley¹

Affiliations

¹ Department of Haematology, Cork University Hospital, Cork, Ireland.
² Haemostasis Molecular Diagnostics Laboratory, National Coagulation Centre, St. James's Hospital, Dublin, Ireland.
³ National Adult Allogeneic Stem Cell Transplant Unit, St. James's Hospital, Dublin, Ireland.

PMID: 35903954
DOI: 10.1111/bjh.18390

No abstract available

Publication types

Letter

MeSH terms

Humans
Leukemia, Myeloid, Acute* / diagnosis
Leukemia, Myeloid, Acute* / genetics
Pedigree
von Willebrand Disease, Type 2*
von Willebrand Diseases* / diagnosis
von Willebrand Factor / genetics

Substances

von Willebrand Factor